Beta-2-glycoprotein-I, infections, antiphospholipid syndrome and therapeutic considerations.
Evidence supports the association between infectious agents, antiphospholipid syndrome (APS), and the presence of antiphospholipid antibodies and anti-beta2-glycoprotein-I (beta2GPI) antibodies. Several mechanisms have been proposed to explain the role of bacteria/viruses in induction of an autoimmune condition, such as molecular mimicry between structures of a pathogen and self antigen and bystander activation or bacterial/viral superantigens. Protein databases reveal high homologies between the beta2GPI-related synthetic peptides and infectious agents. Studies employing experimental APS models proved molecular mimicry between beta2GPI-related synthetic peptides, which serve as target epitopes for anti-beta2GPI Abs, and structures within bacteria, viruses (e.g., CMV), and tetanus toxoid. Any explanation of how microbial infections might induce APS must take into account the genetic predisposition. In this paper, we discuss the association of antiphospholipid antibodies, infectious states, and molecular mimicry as a proposed mechanism for development of APS.
Blank
Miri
M
Department of Medicine B and The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer 52621, Israel.
Shoenfeld
Yehuda
Y
D000818:Animals; D017152:Antibodies, Antiphospholipid / Q000276:immunology; D016736:Antiphospholipid Syndrome / Q000235:genetics / Q000276:immunology* / Q000382:microbiology*; D004195:Disease Models, Animal; D020022:Genetic Predisposition to Disease; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D007239:Infections / Q000276:immunology*; D018716:Molecular Mimicry; D053482:beta 2-Glycoprotein I
D017152:Antibodies, Antiphospholipid; D006023:Glycoproteins; D053482:beta 2-Glycoprotein I